Cited by 19Phytochemicals and Medicinal PlantsAdvanced Proteomics Techniques and ApplicationsProstate Cancer Treatment and Research

SILAC-based quantitative MS approach reveals Withaferin A regulated proteins in prostate cancer

Kumar, Ramesh, Nayak, Debasis, Somasekharan, Syam Prakash·2021·Journal of Proteomics

Abstract

Withaferin A (WA) is a steroidal lactone extracted from Withania somnifera, commonly known as Ashwagandha. WA has several therapeutic benefits. The current study aims to identify proteins that are potentially regulated by WA in prostate cancer (PCA) cells. We used a SILAC-based proteomic approach to analyze the expression of proteins in response to WA treatment at 4 h and 24 h time points in three PCA cell lines: 22Rv1, DU-145, and LNCaP. Ontology analysis suggested that prolonged treatment with WA upregulated the expression of proteins involved in stress-response pathways. Treatment with WA increased oxidative stress, reduced global mRNA translation, and elevated the expression of cytoprotective stress granule (SG) protein G3BP1. WA treatment also enhanced the formation of SGs. The elevated expression of G3BP1 and the formation of SGs might constitute a mechanism of cytoprotection in PCA cells. Knockdown of G3BP1 blocked SG formation and enhanced the efficacy of WA to reduce PCA cell survival. SIGNIFICANCE: Withaferin A, a steroidal lactone, extracted from Withania somnifera is a promising anti-cancer drug. Using a SILAC-based quantitative proteomic approach, we identified proteins changed by WA-treatment at 4 h and 24 h in three prostate cancer (PCA) cell lines. WA-treatment induced the expression of proteins involved in apoptosis and reduced the expression of proteins involved in cell growth at 4 h. WA-treatment for 24 h enhanced the expression of proteins involved in stress response pathways. WA-treated cells exhibited increased oxidative stress, reduced mRNA translation and enhanced SG formation. PCA is characterized by higher metabolic rate and increased oxidative stress. PCA with a higher stress tolerance can effectively adapt to anti-cancer treatment stress, leading to drug resistance and cellular protection. Enhancing the level of oxidative stress along with inhibition of corresponding cytoprotective stress response pathways is a feasible option to prevent PCA from getting adapted to treatment stress. WA-treatment induced oxidative stress, in combination with blocking SGs by G3BP1 targeting, offers a therapeutic strategy to reduce PCA cell survival.

Integrity signals

Registry

Crossref · 10.1016/j.jprot.2021.104334

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

1 retracted

Flagged first, then by citations

1 of the 76 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Kumar, R., Nayak, D., & Somasekharan, S. P.
Affiliations
  • Indian Institute of Technology Indore (IN)
  • Vancouver Prostate Centre (CA)
Corresponding author
Somasekharan, Syam Prakash
Venue
Journal of Proteomics
Publisher
Elsevier BV
Published
2021-09
Volume
247
Pages
104334
ISSN
1874-3919 (ISSN-L)
OpenAlex
W3185321016
Cited by
19
References
76
Citations by year
2026: 2 · 2025: 5 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 2
FWCI
3.38
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Proteomics (publishedVersion)
  • PubMed (publishedVersion)
Funders
Department of Biotechnology, Ministry of Science and Technology, India
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
Keywords
withaferin A, prostate cancer, Withania somnifera, steroidal lactones, G3BP1, stress granules, oxidative stress, mRNA translation, cytoprotection, apoptosis, drug resistance, LNCaP cells, DU145 cells, 22Rv1 cells
MeSH terms
RNA Recognition Motif Proteins, Poly-ADP-Ribose Binding Proteins, DNA Helicases, Humans, Male, Prostatic Neoplasms, RNA Helicases, Proteomics, Withanolides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review